Klotho Neurosciences, Inc. (KLTO)
NASDAQ: KLTO · Real-Time Price · USD
1.105
-0.025 (-2.21%)
Jul 1, 2025, 2:06 PM - Market open
Klotho Neurosciences Employees
Klotho Neurosciences had 3 employees as of December 31, 2024. The number of employees increased by 2 or 200.00% compared to the previous year.
Employees
3
Change
2
Growth
200.00%
Revenue / Employee
n/a
Profits / Employee
-$2,570,770
Market Cap
35.91M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 3 | 2 | 200.00% |
Dec 31, 2022 | 1 | -2 | -66.67% |
Dec 31, 2021 | 3 | 2 | 200.00% |
Dec 31, 2011 | 1 | 0 | - |
Dec 31, 2010 | 1 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
KLTO News
- 1 day ago - This Penny Stock Exploded 500% In June: What You Need To Know - Benzinga
- 1 day ago - Klotho Neurosciences Moves Forward with Manufacturing Gene Therapy for the Treatment of ALS - PRNewsWire
- 7 days ago - Klotho Neurosciences, Inc. and the Okinawa Research Center for Longevity Science, Leading Experts on the Okinawa "Blue Zone", Announce a Plan to Study Tissue Levels of the Human Klotho Gene and Protein in the World's Longest-Lived Population - PRNewsWire
- 13 days ago - KLOTHO NEUROSCIENCES (KLTO) ANNOUNCES MUTUAL TERMINATION OF SHARE EXCHANGE AGREEMENT WITH SKYBELL TECHNOLOGIES (SKYBELL), TO CONTINUE ITS FOCUS ON THERAPEUTICS AND LONGEVITY PROGRAMS - PRNewsWire
- 15 days ago - KLOTHO NEUROSCIENCES RAISES OVER $11 MILLION, RETIRES ALL DEBT, AND EXCEEDS NASDAQ STOCKHOLDERS' EQUITY REQUIREMENT - PRNewsWire
- 21 days ago - Klotho Neurosciences: What's Behind The Nine-Fold Rise In KLTO Stock? - Forbes
- 22 days ago - KLOTHO NEUROSCIENCE, INC. ANNOUNCES AN APPROACH TO INCREASE LONGEVITY AND HEALTHY LIFE SPAN - REPLACE A SILENCED GENE CALLED ALPHA-KLOTHO ("α-KLOTHO") - PRNewsWire
- 6 months ago - Klotho Neurosciences to Present at Biotech Showcase 2025 during J.P. Morgan Healthcare Week in San Francisco - GlobeNewsWire